Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and personalized therapy of midazolam for sedation in Chinese children
ChiCTR2200056773Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Jining Medical University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of midazolam in epilepsy, Physical trauma and Infection, sponsored by Affiliated Hospital of Jining Medical University. Primary endpoints: Drug concentration in plasma and cerebrospinal fluid, Liver and kidney function and 1 more. Started Feb 2022; status: recruiting.
02
Drugs
midazolam
03
Conditions
epilepsyPhysical traumaInfection
Beyond the preview
Go deeper on ChiCTR2200056773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056773.